Joshua D. Stender, Ph.D.
Affiliations: | 2008 | University of Illinois, Urbana-Champaign, Urbana-Champaign, IL |
Area:
BiochemistryGoogle:
"Joshua Stender"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Benita S. Katzenellenbogen | grad student | 2008 | UIUC | |
| (Estrogen receptor dependent gene regulation in human breast cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Abe Y, Kofman ER, Ouyang Z, et al. (2024) A TLR4/TRAF6-dependent signaling pathway mediates NCoR coactivator complex formation for inflammatory gene activation. Proceedings of the National Academy of Sciences of the United States of America. 121: e2316104121 |
| Stolzenburg LR, Esmaeeli S, Kulkarni AS, et al. (2023) Functional characterization of a single nucleotide polymorphism associated with Alzheimer's disease in a hiPSC-based neuron model. Plos One. 18: e0291029 |
| Kastrati I, Joosten SEP, Semina SE, et al. (2020) The NFκB pathway promotes tamoxifen tolerance and disease recurrence in estrogen receptor positive breast cancers. Molecular Cancer Research : McR |
| Cohen Katsenelson K, Stender JD, Kawashima AT, et al. (2019) PHLPP1 counter-regulates STAT1-mediated inflammatory signaling. Elife. 8 |
| Fonseca GJ, Tao J, Westin EM, et al. (2019) Diverse motif ensembles specify non-redundant DNA binding activities of AP-1 family members in macrophages. Nature Communications. 10: 414 |
| Katsenelson KC, Stender JD, Kawashima AT, et al. (2019) Author response: PHLPP1 counter-regulates STAT1-mediated inflammatory signaling Elife |
| Speltz TE, Danes JM, Stender JD, et al. (2018) A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction. Acs Chemical Biology |
| Kastrati I, Brovkovych SD, Stender JD, et al. (2018) Abstract 5242: NFĸB pathway activation is a key determinant of tamoxifen tolerance and recurrence in breast cancer Cancer Research. 78: 5242-5242 |
| Stender JD, Nwachukwu JC, Kastrati I, et al. (2017) Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells. Molecular Cell. 65: 1122-1135.e5 |
| Katsenelson KC, Stender JD, Glass CK, et al. (2017) Abstract 4488: Tumor suppressor phosphatase PHLPP1 regulates transcription factor activity and gene expression in inflammation Cancer Research. 77: 4488-4488 |